Arrowhead Pharmaceuticals
Trade Arrowhead Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ARWR
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC.
ARWR Key Statistics
Stock Snapshot
Arrowhead Pharmaceuticals(ARWR) stock is priced at $62.56, giving the company a market capitalization of 8.76B. It carries a P/E multiple of 40.01.
On 2026-02-12, Arrowhead Pharmaceuticals(ARWR) stock moved within a range of $61.21 to $62.83. With shares now at $62.56, the stock is trading +2.2% above its intraday low and -0.4% below the session's peak.
Trading volume for Arrowhead Pharmaceuticals(ARWR) stock has reached 247.73K, versus its average volume of 5.2M.
Over the past 52 weeks, Arrowhead Pharmaceuticals(ARWR) stock has traded between a high of $76.76 and a low of $9.57.
Over the past 52 weeks, Arrowhead Pharmaceuticals(ARWR) stock has traded between a high of $76.76 and a low of $9.57.
ARWR News
Arrowhead Pharmaceuticals, Inc.'s ( ) earnings announcement last week was disappointing for investors, despite the decent profit numbers. We did some digging an...
Arrowhead Pharmaceuticals (NasdaqGS:ARWR) has been added to the S&P 400 index and its related sector indices. At the same time, the company has been removed fr...
Image source: The Motley Fool. Thursday, February 5, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Dr. Christopher Anzalone Chief Operating...
Analyst ratings
64%
of 14 ratingsMore ARWR News
Earnings Call Insights Arrowhead outlines pivotal 2026 milestones with REDEMPLO launch, $1.33B capital boost, and robust cardiometabolic pipeline Feb. 06, 2026...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.